MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease

被引:56
作者
Allahabadia, A
Heward, JM
Nithiyananthan, R
Gibson, SM
Reuser, TTQ
Dodson, PM
Franklyn, JA
Gough, SCL
机构
[1] Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England
[2] Birmingham Heartlands Hosp, Dept Med, Birmingham B9 5ST, W Midlands, England
[3] Birmingham Heartlands Hosp, Dept Ophthalmol, Birmingham B9 5ST, W Midlands, England
基金
英国惠康基金;
关键词
D O I
10.1016/S0140-6736(01)06125-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Up to half of patients with Graves' hyperthyroidism have signs of thyroid associated ophthalmopathy, but the factors that cause this disorder are unknown. We Investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic T lymphocyte antigen-4 (CTLA4) gene. Allelic frequencies of these genes In patients with Graves' disease who did and did not have concurrent thyroid-associated ophthalmopathy did not differ, and are, therefore, unlikely to contribute to its development.
引用
收藏
页码:984 / 985
页数:2
相关论文
共 5 条
[1]   The development of Graves' disease and the CTLA-4 gene on chromosome 2q33 [J].
Heward, JM ;
Allahabadia, A ;
Armitage, M ;
Hattersley, A ;
Dodson, PM ;
MacLeod, K ;
Carr-Smith, J ;
Daykin, J ;
Daly, A ;
Sheppard, MC ;
Holder, RL ;
Barnett, AH ;
Franklyn, JA ;
Gough, SCL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (07) :2398-2401
[2]   Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: Replication using a population case control and family-based study [J].
Heward, JM ;
Allahabadia, A ;
Daykin, J ;
Carr-Smith, J ;
Daly, A ;
Armitage, M ;
Dodson, PM ;
Sheppard, MC ;
Barnett, AH ;
Franklyn, JA ;
Gough, SCL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10) :3394-3397
[3]   Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy [J].
Vaidya, B ;
Imrie, H ;
Perros, P ;
Dickinson, J ;
McCarthy, MI ;
Kendall-Taylor, P ;
Pearce, SHS .
LANCET, 1999, 354 (9180) :743-744
[4]   Medical progress: Graves' disease. [J].
Weetman, AP .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (17) :1236-1248
[5]   MODIFICATION OF CLASSIFICATION OF EYE CHANGES OF GRAVES-DISEASE - RECOMMENDATIONS OF AD-HOC COMMITTEE OF AMERICAN THYROID ASSOCIATION [J].
WERNER, SC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 44 (01) :203-204